Schnieders Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$695K Buy
7,576
+1,709
+29% +$150K 0.09% 121
2026
Q1
$500K Sell
5,867
-100
-2% -$8.91K 0.08% 130
2025
Q4
$472K Sell
5,967
-600
-9% -$47K 0.07% 138
2025
Q3
$525K Sell
6,567
-5,927
-47% -$506K 0.09% 128
2025
Q2
$1.14M Buy
12,494
+245
+2% +$22.4K 0.2% 78
2025
Q1
$1.15M Sell
12,249
-500
-4% -$44.8K 0.25% 71
2024
Q4
$1.16M Sell
12,749
-57
-0.4% -$5.44K 0.23% 77
2024
Q3
$1.33M Sell
12,806
-1,543
-11% -$157K 0.25% 65
2024
Q2
$1.39M Sell
14,349
-250
-2% -$23.1K 0.28% 60
2024
Q1
$1.31M Sell
14,599
-250
-2% -$21.2K 0.27% 67
2023
Q4
$1.18M Sell
14,849
-6,495
-30% -$488K 0.26% 72
2023
Q3
$1.52M Sell
21,344
-3,171
-13% -$237K 0.34% 57
2023
Q2
$1.89M Hold
24,515
0.39% 57
2023
Q1
$1.84M Sell
24,515
-7,070
-22% -$526K 0.41% 56
2022
Q4
$2.49M Buy
31,585
+8,171
+35% +$613K 0.57% 49
2022
Q3
$1.65M Buy
23,414
+11,296
+93% +$886K 0.44% 52
2022
Q2
$971K Sell
12,118
-110
-0.9% -$8.6K 0.29% 73
2022
Q1
$927K Sell
12,228
-23
-0.2% -$1.82K 0.22% 86
2021
Q4
$1.05M Buy
12,251
+1,324
+12% +$103K 0.24% 79
2021
Q3
$826K Sell
10,927
-993
-8% -$78.8K 0.22% 83
2021
Q2
$970K Sell
11,920
-62
-0.5% -$5.07K 0.26% 73
2021
Q1
$945K Hold
11,982
0.28% 71
2020
Q4
$1.02M Sell
11,982
-1,500
-11% -$124K 0.34% 62
2020
Q3
$1.04M Hold
13,482
0.39% 58
2020
Q2
$988K Sell
13,482
-245
-2% -$17.4K 0.39% 58
2020
Q1
$911K Sell
13,727
-255
-2% -$18K 0.44% 56
2019
Q4
$963K Hold
13,982
0.35% 73
2019
Q3
$1.03M Sell
13,982
-300
-2% -$21.8K 0.41% 67
2019
Q2
$1.02M Sell
14,282
-48
-0.3% -$3.41K 0.4% 68
2019
Q1
$982K Sell
14,330
-325
-2% -$21K 0.42% 65
2018
Q4
$872K Sell
14,655
-1,928
-12% -$121K 0.43% 63
2018
Q3
$1.11M Sell
16,583
-275
-2% -$18.3K 0.46% 64
2018
Q2
$1.09M Sell
16,858
-2,168
-11% -$142K 0.46% 63
2018
Q1
$1.36M Sell
19,026
-3,776
-17% -$272K 0.59% 54
2017
Q4
$1.72M Hold
22,802
0.71% 48
2017
Q3
$1.66M Sell
22,802
-50
-0.2% -$3.6K 0.73% 49
2017
Q2
$1.69M Sell
22,852
-30
-0.1% -$2.23K 0.79% 47
2017
Q1
$1.68M Buy
22,882
+250
+1% +$17.5K 0.8% 42
2016
Q4
$1.48M Buy
22,632
+1,710
+8% +$117K 0.76% 43
2016
Q3
$1.55M Sell
20,922
-100
-0.5% -$7.39K 0.87% 37
2016
Q2
$1.54M Sell
21,022
-349
-2% -$24.9K 0.86% 38
2016
Q1
$1.51M Sell
21,371
-549
-3% -$36.5K 0.89% 38
2015
Q4
$1.46M Buy
21,920
+225
+1% +$15K 0.9% 39
2015
Q3
$1.38M Buy
21,695
+2,100
+11% +$137K 0.95% 36
2015
Q2
$1.28M Sell
19,595
-1,040
-5% -$70.5K 0.75% 43
2015
Q1
$1.43M Buy
20,635
+920
+5% +$63.6K 0.87% 41
2014
Q4
$1.36M Buy
19,715
+421
+2% +$28.4K 0.9% 38
2014
Q3
$1.26M Buy
19,294
+1,500
+8% +$98.9K 0.93% 35
2014
Q2
$1.21M Buy
17,794
+2,450
+16% +$164K 0.86% 38
2014
Q1
$995K Buy
15,344
+400
+3% +$25.2K 0.92% 38
2013
Q4
$974K Buy
+14,944
New +$956K 0.95% 36

Other funds holding CL

Schnieders Capital Management's CL Position: Q2 2026 in Review

Schnieders Capital Management increased its Colgate-Palmolive (CL) stake by 29% in Q2 2026, buying an estimated $150K and bringing the position to 7,576 shares worth $695K. The position accounts for 0.09% of the portfolio, ranked #121.

Schnieders Capital Management first reported a position in CL in Q4 2013 and has held it in 51 quarters since. The position peaked at $2.49M in Q4 2022. 623 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Schnieders Capital Management held 7,576 shares of Colgate-Palmolive worth $695K as of Q2 2026.
  • Schnieders Capital Management bought 1,709 Colgate-Palmolive shares in Q2 2026, an estimated $150K.
  • Colgate-Palmolive made up 0.09% of Schnieders Capital Management's portfolio in Q2 2026, its #121 holding.
  • Schnieders Capital Management first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 51 quarters since.
  • Schnieders Capital Management's Colgate-Palmolive position peaked at $2.49M in Q4 2022.
  • 623 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Schnieders Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.